| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KALV | Common Stock | Purchase | $1,274,793 | +88,099 | +1.9% | $14.47 | 4,738,683 | 30 Jan 2024 | By Funds | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.25 to $14.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F2 | Consists of (i) 1,036,431 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 103,678 shares held by VHCP Co-Investment Holdings III,LLC ("VHCP Co-3"); and (iii) 3,598,574 shares held by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). |
| F3 | VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these shares. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these shares. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these shares. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein. |